Clinical Trial

Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 20, 2024 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.
Summary
Aim of this study is to optimize an adherence increasing intervention designed for metastatic Breast Cancer (BC) patients by applying a full factorial design in order to evaluate the optimal combination of three different intervention components.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-05.
Trial Details
NCT Number NCT06726889
Lead Sponsor European Institute of Oncology
Conditions Breast Cancer
Enrollment 104 participants
Start Date 2024-01-25
Primary Completion 2025-04 (estimated)
Study Completion 2025-04 (estimated)
Updated on ClinicalTrials.gov 2024-12-20